| Income Statement | 2025-06-30 | 2025-03-31 | 2024-06-30 | |
|---|---|---|---|---|
| Total other (expense) income | -13,539 | -11,586 | 2,164 | |
| (loss) income before income tax expense and noncontrolling interest | -179,089 | 369,616 | -173,977 | |
| Income tax (benefit) expense | -437 | 1,753 | - | |
| Net (loss) income including noncontrolling interest | -178,652 | 367,863 | -173,977 | |
| Net loss attributable to noncontrolling interest, net of tax | -3,411 | -2,582 | -3,184 | |
| Net (loss) income attributable to arrowhead pharmaceuticals, inc | -175,241 | 370,445 | -170,793 | |
| Basic (in dollars per share) | -1.26 | 2.78 | -1.38 | |
| Basic (in shares) | 139,039,000 | 133,363,000 | 124,199,000 | |
| Diluted (in dollars per share) | -1.26 | 2.75 | -1.38 | |
| Diluted (in shares) | 139,039,000 | 134,484,000 | 124,199,000 | |
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)